Evident Vascular is developing an advanced intravascular ultrasound (IVUS) platform technology designed initially for peripheral vascular interventions, with future capability for coronary procedures. Leveraging artificial intelligence (AI) to enable superior image interpretation and streamlined workflows, Evident Vascular's technology has been designed to expand adoption of IVUS, driving increased market penetration and enabling improved clinical outcomes with faster, more accurate diagnosis and treatment decisions.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/17/23 | $35,000,000 | Series A |
Vensana Capital | undisclosed |
